Skip to main content
Contact Us
Subscribe
E-Edition
70°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Better Therapeutics, Inc.
< Previous
1
2
Next >
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
March 14, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
March 05, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
March 04, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
February 20, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
January 02, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions
November 28, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award
November 14, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 09, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual Conference
October 26, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
October 16, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces Publication of LivVita Liver Disease Study Results in Gastro Hep Advances
October 05, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx and GLP-1 Receptor Agonists to Treat Type 2 Diabetes
October 11, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Completes Enrollment in Real-World Evidence Program Evaluating Long-term Effectiveness of AspyreRx in Type 2 Diabetes
September 28, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 09, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 09, 2023
August 02, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
July 25, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Receives FDA Authorization for AspyreRx™ to Treat Adults with Type 2 Diabetes
July 10, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria
June 16, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
May 11, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023
May 04, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces $6.5MM Private Placement
April 06, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 30, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023
March 23, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics to Participate in Two Upcoming Investor Conferences
February 09, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
December 08, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics to Participate in BTIG Digital Health Forum
November 15, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 14, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022
November 07, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer
October 27, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Tickers
BTTX
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.